Bharat Serums and Vaccines Limited Sustainability Profile
Bharat Serums and Vaccines Limited, commonly referred to as BSV, is a prominent player in the biopharmaceutical industry, headquartered in Mumbai, India. Founded in 1971, the company has established itself as a leader in the development and manufacturing of high-quality serums, vaccines, and biopharmaceutical products, catering to both domestic and international markets. With a strong focus on innovation, BSV offers a diverse range of products, including immunoglobulins, vaccines, and critical care solutions, distinguished by their rigorous quality standards and advanced manufacturing processes. The company has achieved significant milestones, including regulatory approvals and partnerships that enhance its market position. Recognised for its commitment to healthcare, Bharat Serums and Vaccines Limited continues to contribute to the global fight against infectious diseases, solidifying its reputation as a trusted name in the biopharmaceutical sector.
DitchCarbon Score
How does Bharat Serums and Vaccines Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Bharat Serums and Vaccines Limited's score of 31 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Bharat Serums and Vaccines Limited, headquartered in India, currently does not have specific carbon emissions data available for the most recent year. The company is a current subsidiary of Mankind Pharma Limited, from which it inherits emissions data and climate performance metrics. However, no specific emissions figures or reduction targets have been disclosed. As part of its commitment to sustainability, Bharat Serums and Vaccines Limited is aligned with broader industry initiatives, although specific climate pledges or reduction targets have not been detailed. The company’s climate strategy may be influenced by the practices and commitments of its parent company, Mankind Pharma Limited, which operates within the pharmaceutical sector. In summary, while Bharat Serums and Vaccines Limited does not currently report specific emissions data or reduction targets, it is positioned within a corporate family that may guide its climate commitments and performance.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 15,753,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 28,074,000 | - | 00,000,000 |
| Scope 3 | 168,000 | - | - |
How Carbon Intensive is Bharat Serums and Vaccines Limited's Industry?
How Carbon Intensive is Bharat Serums and Vaccines Limited's Location?
Bharat Serums and Vaccines Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Bharat Serums and Vaccines Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
